Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation

Molecular Biology of the Cell

Volumn 10, Issue 5, 1999, Pages 1569-1579

  Bradshaw, Amy D ^a   Francki, Aleksandar ^a   Motamed, Kouros ^a   Howe, Chin ^c   Sage, E Helene ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WISTAR INSTITUTE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; OSTEONECTIN; REGULATOR PROTEIN; VINCULIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; FIBROBLAST; GROWTH REGULATION; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SMOOTH MUSCLE FIBER;

ANIMALIA;

EID: 0032930174     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.5.1569     Document Type: Article

References (31)

1. Alexandrow, M.G., and Moses, H.L. (1997). Kips off to myc: implications for TGF-β signaling. J. Cell. Biochem. 66, 427-432.
2. Bassuk, J.A., Baneyx, P., Vernon, R.B., Funk, S.E., and Sage, E.H. (1996). Expression of biologically active human SPARC in Escherichia coli. Arch. Biochem. Biophys. 325, 8-19.
3. Bassuk, J.A., Birkebak, T., Rothmier, J.D., Clark, J.M., Bradshaw, A., Muchowski, P.J., Howe, C.C., Clark, J.I., and Sage, E.H. (1999). Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. Exp. Eye Res. 68, 321-331.
4. Damsky, C.H., and Werb, Z. (1992). Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular matrix information. Curr. Opin. Cell Biol. 4, 772-781.
5. Delany, A., Amling, M., Priemel, M., Delling, G., Howe, C., Baron, R., and Canalis, E. (1998). Osteonectin null mice develop severe osteopenia. Bone 23, 199S.
6. Francki, A., Bradshaw, A.D., Bassuk, J.A., Carbon, J.G., Howe, C., and Sage, E.H. (1998). SPARC regulates collagen type I and TGF-β1 expression in mouse mesangial cells. Mol. Biol. Cell 9(suppl), 167a (abstract).
7. Francki, A., Uciechowski, P., Floege, J., Von der Ohe, J., Resch, K., and Radeke, H.H. (1995). Autocrine growth regulation of human glomerular mesangial cells is primarily mediated by basic fibroblast growth factor. Am. J. Pathol. 147, 1372-1382.
8. 2+-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88, 2648-2652.
9. Funk, S.E., and Sage, E.H. (1993). Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J. Cell Physiol. 154, 53-63.
10. Gilmour, D.T., Lyon, G.J., Carlton, M.B.L., Sanes, J.R., Cunningham, J.M., Anderson, J.R., Hogan, B.L.M., Evans, M.J., and Colledge, W.H. (1998). Mice deficient for the secreted glycoprotein SPARC/ osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J. 17, 1860-1870.
11. Hasselaar, P., Loskutoff, D.J., Sawdey, M., and Sage, E.H. (1991). SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells. J. Biol. Chem. 266, 13178-13184.
12. Hasselaar, P., and Sage, E.H. (1992). SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J. Cell. Biochem. 49, 272-283.
13. Ilic, D., et al. (1995). Reduced motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544.
14. Iruela-Arispe, L.M., Vernon, R. B., Wu, H., Jaenisch, R., and Sage, E.H. (1996). Type I collagen-deficient mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function. Dev. Dyn. 207, 171-183.
15. Ko, T.C., Yu, W., Sakai, T., Sheng, H., Shao, J., Beauchamp, R.D., and Thompson, E.A. (1998). TGF-β1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression. Oncogene 16, 3445-3454.
16. Kupprion, C., Motamed, K., and Sage, E.H. (1998). SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J. Biol. Chem. 273, 29635-29640.
17. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227, 680-685.
18. ++-binding sites modulate cell shape. J. Cell Biol. 111, 3065-3076.
19. Lane, T.F., and Sage, E.H. (1994). The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8, 163-173.
20. Mok, S.C., Chan, W.Y., Wong, K.K., Muto, M.G., and Berkowitz, R.S. (1996). SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene 12, 1895-1901.
21. Motamed, K., and Sage, E.H. (1998). SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J. Cell. Biochem. 70, 543-552.
22. 2+-binding EF-hand. J. Cell. Biochem. 57, 341-350.
23. Norose, K., Clark, J.I., Syed, N.A., Basu, A., Heberkaty, E.S., Sage, E.H., and Howe, C.C. (1998). SPARC deficiency leads to early onset cataractogenesis. Invest. Ophthal. Vis. Sci. 39, 2674-2680.
24. Otto, J.J. (1990). Vinculin. Cell Motil. Cytoskeleton 16, 1-6.
25. Pichler, R.H., et al. (1996). SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-mediated mesangial cell proliferation in vitro. Am. J. Pathol. 148, 1153-1167.
26. Raines, E.W., Lane, T.F., Iruela-Arispe, M.L., Ross, R., and Sage, E.H. (1992). The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad. Sci. USA 89, 1281-1285.
27. 2+-dependent binding to the extracellular matrix. J. Cell Biol. 109, 341-356.
28. Sasaki, T., Göhring, W., Mann, K., Maurer, P., Hohenester, E., Knauper, V., Murphy, G., and Timpl, R. (1997). Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J. Biol. Chem. 272, 9237-9243.
29. Shankland, S.J. (1996). Cell-cycle control and renal disease. Kidney Intl. 52, 294-308.
30. Tremble, P.M., Lane, T.F., Sage, E.H., and Werb, Z. (1993). SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J. Cell Biol. 121, 1433-1444.
31. Yu, D-H., Qu, C.-K., Henegariu, O., Lu, X., and Feng, G.-S. (1998). Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J. Biol. Chem. 273, 21125-21131.